In the News August 3, 2018

Bloomberg Law | Stem Cell Clinics Face Long Odds against FDA in Legal Fight

Marc Scheineson is quoted on how legal actions by the U.S. Food and Drug Administration against stem cell clinics are shaping regenerative medicine regulations.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.